External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps Mehdi El HassaniAmélie Marsot Current Opinion 01 April 2023 Pages: 533 - 540
Clinical Pharmacokinetics and Pharmacodynamics of CSL112 Luis Ortega-PazSalvatore GiordanoDominick J. Angiolillo Review Article 16 March 2023 Pages: 541 - 558
Pharmacokinetics and Pharmacodynamics of Ruxolitinib: A Review T. Y. J. AppeldoornT. H. Oude MunninkD. J. Touw Systematic Review Open access 31 March 2023 Pages: 559 - 571
Population Pharmacokinetics and Dosing Simulations of Ampicillin and Sulbactam in Hospitalised Adult Patients Eko SetiawanMenino Osbert CottaJason A. Roberts Original Research Article Open access 28 February 2023 Pages: 573 - 586
Population Pharmacokinetics and Exposure–Response Analysis for the Phase 3 COSMIC-311 Trial of Cabozantinib for Radioiodine-Refractory Differentiated Thyroid Cancer Neang S. LyJing LiMarcia S. Brose Original Research Article Open access 04 March 2023 Pages: 587 - 598
Evaluation of CYP2C19-Mediated Pharmacokinetic Drug Interaction of Tegoprazan, Compared with Vonoprazan or Esomeprazole Eunsol YangSang Chun JiSeungHwan Lee Original Research Article Open access 10 March 2023 Pages: 599 - 608
Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist Islam YounisElijah WeberAhmed A. Othman Original Research Article Open access 11 March 2023 Pages: 609 - 621
Assessing the Impact of Immunogenicity and Improving Prediction of Trough Concentrations: Population Pharmacokinetic Modeling of Adalimumab in Patients with Crohn’s Disease and Ulcerative Colitis Ana Victoria Ponce-BobadillaSven StodtmannNael M. Mostafa Original Research Article 11 March 2023 Pages: 623 - 634
Effect of Various Dosing Schedules on the Pharmacokinetics of Oral Semaglutide: A Randomised Trial in Healthy Subjects Marloes van HoutPablo ForteTine A. Bækdal Original Research Article Open access 17 March 2023 Pages: 635 - 644
Pharmacokinetics, Safety, and Tolerability of Glepaglutide, a Long-Acting GLP-2 Analog, in Subjects with Renal Impairment Mikkel Askjær AgersnapKim SonneWladyslaw Sulowicz Original Research Article Open access 21 February 2023 Pages: 645 - 651
Correction to: Pharmacokinetics, Safety, and Tolerability of Glepaglutide, a Long-Acting GLP-2 Analog, in Subjects with Renal Impairment Mikkel Askjær AgersnapKim SonneWladyslaw Sulowicz Correction Open access 13 March 2023 Pages: 653 - 654